Notice of Intent to Publish a Funding Opportunity Announcement for Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed)

0
123

Opportunity ID: 325182
Opportunity Number: NOT-AI-20-032
Opportunity Title: Notice of Intent to Publish a Funding Opportunity Announcement for Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.855
Eligible Applicants: State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility:
Agency Code: HHS-NIH11
Agency Name: Department of Health and Human Services
National Institutes of Health
Posted Date: Mar 05, 2020
Last Updated Date: Mar 05, 2020
Estimated Synopsis Post Date: Jun 16, 2020
Fiscal Year: 2021
Award Ceiling: $35,000,000
Award Floor:
Estimated Total Program Funding:
Expected Number of Awards: 6
Description: The National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) intend to publish Funding Opportunity Announcements (FOAs) for the Martin Delaney Collaboratories (MDC) for HIV Cure Research program, a cooperative partnership between academia, industry, government, and community aimed at developing innovative strategies for cure or sustained remission of persistent HIV infection (https://www.niaid.nih.gov/research/mdc). Two separate FOAs will be issued: one will be a re-issue of the Martin Delaney Collaboratories for HIV Cure Research (UM1) FOA, and the other will be a new FOA for an MDC focused specifically on HIV cure research in pediatric populations. Only new applications will be accepted under both FOAs; competitive renewal applications from existing awards will not be accepted. This Notice is being issued to allow potential applicants more time to consider the requirements of this program and to develop responsive projects.
Version: 1





Visit the Official Webpage For More Details on Notice of Intent to Publish a Funding Opportunity Announcement for Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed)